Jazz Pharmaceuticals plc earnings per share and revenue

JAZZ earnings per share for the last quarter are 6.60 USD whereas the estimation was 5.86 USD which accounts for 12.60% surprise. Company revenue for the same period amounts to 1.09 B USD despite the estimated figure of 1.06 B USD. Estimated earnings per share for the next quarter are 4.82 USD, and revenue is expected to reach 983.80 M USD. Also watch annual changes over time to get a bigger picture of JAZZ earnings per share and revenue dynamics.